Connect with us


CBD Treatment Case Fungal Infection



In the early 1980s, there were some discoveries that led to an understanding that CBD was a particularly important part of the equation of trying to battle against fungal infection. In fact, we have seen noteworthy antifungal properties demonstrated by several different cannabinoids found in the cannabis plant: CBD, CBG, and CBC.

One might ask oneself, why on earth should this be the case?

In fact, it has to do with something of an ultimately Darwinian origin. As we now understand it, these particular cannabinoids function as the evolved defense of the cannabis plant and its leaves and flowers against attackers from the bacterial or fungal realm.

Another consequence of this outcome is that farming cannabis and hemp is particularly easy because the plants come with a ready-made internal defense and therefore demand far less in the way of pesticides and other dangerous chemicals that threaten the soil of the farm.

Evolution, Terpenes, Cannabinoids, and Defense

As noted above, this strange mix of internal defense is due to the presence of certain potent cannabinoids. However, there is also another weapon in this plant’s arsenal that comes in the form of a terpene known as caryophyllene oxide.

While this particular terpene is precisely the stuff that alerts drug sniffing dogs in a canine unit to the presence of marijuana in an airport, it is also a potent and powerful weapon in the war against fungus.

Terpenes are actually a class of compound that is found across the plant kingdom. They are most important in terms of their production of smells on the spectrum that human beings respond to in a significant manner. Anytime that you decide that a particular plant has a particular scent, you are responding to terpenes found in that plant.

But there are many other functions of these compounds, including anti-inflammatory, palliative, and anxiety-reducing functions.

This is because terpenes and cannabinoids share a common precursor in the biochemical pathways of time. And that means they have a puzzle-piece relationship with the enzymatic and endocannabinoid systems found in the human body.

As we apply these thoughts to fungal infections, it is important to understand that playing field, which brings us to an important issue: Many people confuse and conflate the concepts of bacteria and fungus.

The Five Kingdoms

In fact, this is an error: bacteria are entirely separate from the rest of the kingdoms of life in a primary sense given the fact that they are prokaryotic – meaning that their basic cell structure lacks a nucleus.

By contrast the other four principal kingdoms of life – fungus, protists, plants, and animals – all our eukaryotic (meaning that they’re based on a cell structure that includes a nucleus). Hence, when trying to find ways to kill bacteria, it’s quite easy because most of the things that kill bacteria won’t also kill the cells in your own body.

However, if you’re trying to kill off a fungal infection, you’re going to need to use tools that kill eukaryotic cells, of which your own body is made. This makes the job of defending against a fungal infection far more complicated than that of defending against a bacterial infection, as you might imagine.

It turns out that CBD is an extraordinary tool because of the existence of cannabinoids evolved to protect the plant against fungal infection.

For example, with CBD, CBG and CBC both caused eradication of onychomycosis in a clinical study. This is a common fungal infection in humans. The cannabinoid solution worked at rates comparable to cyclopiroxolamine and sulconazole, two common pharmaceutical antifungals.

The Path Forward

While we don’t understand precisely the way in which these compounds function so effectively in the fight against fungal infections, we do understand that they appear to work just as comprehensively and effectively as common current pharmaceutical solutions.

The goal from here is about further research, some fine-tuning, and spreading awareness

Continue Reading


CannTrust Holdings Inc (NYSE:CTST) Penetrates Into The United States After Investing $20 Million



CannTrust Holdings Inc (NYSE:CTST), a Canadian company that produces and sells medical and recreational marijuana has announced the expansion of its business into the United States.

The Canadian firm revealed that it signed a Letter of Intent through which it will start working with Elk Grove Farming Company, LLC to access more than 3,000 hemp production acres in California. The two companies struck a joint partnership that will allow CannTrust to secure a footing in the California market which is one of the biggest cannabis markets in the U.S.

“This agreement represents another bold move for CannTrust. Our U.S. operation is expected to deliver a significant increase in low-cost production capacity,” stated CannTrust CEO Peter Aceto.

CannTrust is financially ready to tap into the U.S market

The CannTrust CEO also noted that the company will take advantage of its experience in the formulation of standardized CBD products as part of its strategy to enter the U.S market. Mr. Aceto also revealed that his company’s successful equity offering provided enough financial muscle to fuel its ambitious expansion plans.

CannTrust aims to be among the leading and trusted suppliers of high-quality, standardized CBD formulations derived from hemp. The company believes that there will be an increasing demand for high-grade CBD formulations from international retailers. It therefore makes sense to invest in processes that will add value to the end product such as genetic studies and expert growing practices to achieve the highest safety and quality standards.

Elk Grove and CannTrust will each have 50% ownership in their joint operations. Elk Grove is an ideal partner for the endeavor because it has years of farming experience in a variety of products. Its focus includes products designed for crop protection, supply, and input. Its operations are distributed across California, which means that the groundwork has already been laid for the partnership. It will thus be easier for the CannTrust to penetrate into the California market.

Elk Grove executive Morgan Houchin stated that his company was excited about the partnership with CannTrust. He added that his firm’s experience in farming operations will be a great combination with CannTrust’s experience in creating class-leading formulations.

Continue Reading


Rocky Mountain High Brands Inc (OTCMKTS:RMHB) Strikes Broker Deal With Carlin Group



Lifestyle brand management firm Rocky Mountain High Brands Inc (OTCMKTS:RMHB) announced on Wednesday that it secured a broker deal with Carlin Group for its products in the retail space.

The broker agreement will allow Carlin to represent RMHB’s CBD-infused drinks through the HEMPd brand. It will also represent beverages infused with Hempseed extract under RMHB brands. The deal will also cover CBD-infused wellness products such as lotions, water-soluble solutions, capsules, gummies and tinctures as part of the HEMPd brand. Spirit Water will also be covered under the agreement.

The RMHB-Carlin broker deal covers multiple states. They include Missouri, Nebraska, Texas, South Dakota, North Dakota, Minnesota, Wisconsin, Illinois, Pennsylvania, Tennessee, Kentucky, Ohio, Indiana, and Michigan.

“We are very excited about the opportunity to have our entire product line represented by Carlin Group,” stated RMHB CEO Michael Welch.

The Carlin broker deal will boost RMHB’s exposure

Welch noted that the broker deal will strategically allow RMHB to leverage optimal exposure to mass marketers, grocery store chains, convenient stores, major retailers and other types of outlets. The company would not have managed to reach such a wide range of outlets cost-effectively without a broker deal.

The RMHB CEO also added that his company and Carlin will maintain a close collaboration so that they can facilitate retail availability of RMHB products. Welch also revealed that RMHB reviewed numerous other retail introduction options. This was before settling on Carlin which the company believes is the best-suited brand to rapidly get its products onto retail shelves.

Carlin Group’s Managing Director Albert Vergilio noted in a statement that his company was excited to host RMHB and the CBD-based products that are part of its HEMPd brand in Carlin’s new CBD division. He also added that it is part of investing in the future of CBD considering the fast-tracked popularity of CBD products, and the regulations that govern them.

Carlin’s sales team will undergo some training to get them acquainted with RMBH’s products. The sales team will then hold meetings with corporate customers as part of the retail rollout of the products. Sales that will be part of the broker deal are expected to kick off in Q3.

Continue Reading


Wildflower Brands Inc (OTCMKTS:WLDFF) Establishes Footprint Across The US With PO For Hemp CBD Products From Dillard’s Department Stores And Eyes Markets In Texas And Florida



Wildflower Brands Inc (OTCMKTS:WLDFF) has announced establishing a nationwide presence with a PO from Dillard’s Department store. The company has fulfilled the PO received from Dillard.

Hemp CBD products in 292 locations

Dillard’s department store will showcase the premium hemp CBD products of Wildflower in its 292 locations across the US. With its best practices and transparency, Wildflower is eyeing the key markets in Texas and Florida. The company will educate the customers in these regions about salable products. Wildflower has received subsequent orders from Dillard’s and is fulfilling the requirements.

Chief Executive Officer of Wildflower, William Maclean said the supply of CBD infused products to Dillard’s Department stores doubles the existing retail locations in the nation. The company aims to capitalize on its brand to become a household name. It will improve loyalty building because of the reputation and respect of Dillard’s as a retailer. Wildflower aims to provide health and wellness benefits of its CBD infused products to the customers in the US through Dillard’s.

Signs a deal with Highmark Interactive

Wildflower has signed a deal to use EQ – Brain Tracking, mobile software of Highmark Interactive, in the clinical research to study the functional neurological and cognitive effects of CBD. The company aims to get meaningful results and data that help to understand the functional and cognitive neurological properties of the cannabinoids.

William said the company would collect testimonials from the customers on its products that provide the health and wellness needs using plant-based solutions. The company will strive to improve the products, and the research helps it to reach that goal and growth with continued investments.

Acquires City Cannabis Corp

Wildflower has signed an LOI on April 3, 2019, to take over City Cannabis Corp. The company will issue its 60 million common shares for the takeover. The companies will complete the acquisition on receiving advice from corporate, tax, and securities law departments.

The cannabis retailer City Cannabis holds two licenses in the City of Vancouver to market cannabis. It is generating profits through operating dispensaries in Vancouver. The acquisition helps Wildflower to expand retail footprint using the expertise of City Cannabis.

Continue Reading

Trending Stories